SCHEMBL1090351

SCHEMBL1090351

N#Cc1ccc(S(=O)(=O)N2CCC(N3CCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CCR6 P51684 9/20 0.49
▸ CXCR4 P61073 1/20 0.46
▸ EPHX2 P34913 1/20 0.44
▸ IKBKB O14920 4/20 0.43
▸ HSD11B1 P28845 2/20 0.43
▸ CCNA2 P20248 2/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ MAPK8 P45983 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CCNK O75909 1/20 0.42
▸ CDK12 Q9NYV4 1/20 0.42
▸ CHUK O15111 1/20 0.42
▸ MAPK9 P45984 1/20 0.42
▸ MAPK10 P53779 1/20 0.42
▸ MAPK11 Q15759 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090195 0.96 EPHX2 (0.47) CCR6CXCR4EPHX2IKBKBHSD11B1
SCHEMBL1089244 0.96 CCR6 (0.46) CCR6CXCR4EPHX2IKBKBHSD11B1
SCHEMBL1090132 0.92 CXCR4 (0.45) CCR6CXCR4IKBKBHSD11B1MAPK8
SCHEMBL1090617 0.89 ALDH1A1 (0.53) CCR6CXCR4IKBKBCDK2MAPK8
SCHEMBL1090432 0.89 ALDH1A1 (0.53) CCR6CXCR4IKBKBMAPK8CHUK
SCHEMBL1091155 0.89 CXCR4 (0.56) CXCR4IKBKBMAPK8GAAL3MBTL1
SCHEMBL1090720 0.88 HSD11B1 (0.43) CCR6CXCR4EPHX2IKBKBHSD11B1
SCHEMBL1089268 0.88 HRH4 (0.44) CCR6CXCR4EPHX2IKBKBHSD11B1
SCHEMBL1090135 0.86 MEN1 (0.49) CCR6CXCR4EPHX2IKBKBCCNA2
SCHEMBL1091267 0.86 ALDH1A1 (0.56) CCR6CXCR4EPHX2IKBKBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CCR6 18/4885CXCR4 1/4885EPHX2 494/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CCR6 18/4885CXCR4 1/4885EPHX2 494/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CCR6 18/4885CXCR4 1/4885EPHX2 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback